News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,788 Results
Type
Article (54790)
Company Profile (478)
Press Release (706504)
Multimedia
Podcasts (171)
Webinars (26)
Section
Business (210375)
Career Advice (3272)
Deals (36715)
Drug Delivery (145)
Drug Development (85115)
Employer Resources (196)
FDA (17363)
Job Trends (14934)
News (358317)
Policy (33982)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2823)
Academic (1)
Accelerated approval (38)
Adcomms (36)
Allergies (157)
Alliances (51004)
ALS (184)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (366)
Approvals (17571)
Artificial intelligence (617)
Autoimmune disease (184)
Automation (43)
Bankruptcy (347)
Best Places to Work (11955)
BIOSECURE Act (22)
Biosimilars (209)
Biotechnology (332)
Bladder cancer (165)
Brain cancer (67)
Breast cancer (684)
Cancer (5206)
Cardiovascular disease (462)
Career advice (2784)
Career pathing (42)
CAR-T (317)
CDC (55)
Celiac Disease (2)
Cell therapy (866)
Cervical cancer (38)
Clinical research (72543)
Collaboration (1889)
Company closure (5)
Compensation (1219)
Complete response letters (76)
COVID-19 (2797)
CRISPR (107)
C-suite (935)
Cystic fibrosis (154)
Data (6555)
Decentralized trials (2)
Denatured (51)
Depression (155)
Diabetes (545)
Diagnostics (6949)
Digital health (52)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (312)
Drug pricing (219)
Drug shortages (36)
Duchenne muscular dystrophy (256)
Earnings (93762)
Editorial (69)
Employer branding (24)
Employer resources (166)
Events (126995)
Executive appointments (1035)
FDA (20649)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1593)
Gene editing (230)
Generative AI (61)
Gene therapy (707)
GLP-1 (1132)
Government (4912)
Grass and pollen (8)
Guidances (386)
Healthcare (19731)
HIV (75)
Huntington's disease (53)
IgA nephropathy (88)
Immunology and inflammation (301)
Immuno-oncology (74)
Indications (126)
Infectious disease (3093)
Inflammatory bowel disease (213)
Inflation Reduction Act (17)
Influenza (124)
Intellectual property (266)
Interviews (630)
IPO (17484)
IRA (57)
Job creations (3337)
Job search strategy (2254)
JPM (71)
Kidney cancer (19)
Labor market (98)
Layoffs (611)
Leadership (42)
Legal (8008)
Liver cancer (97)
Longevity (18)
Lung cancer (701)
Lymphoma (391)
Machine learning (45)
Management (64)
Manufacturing (883)
MASH (177)
Medical device (14450)
Medtech (14513)
Mergers & acquisitions (20376)
Metabolic disorders (1436)
mRNA (191)
Multiple sclerosis (172)
NASH (23)
Neurodegenerative disease (374)
Neuropsychiatric disorders (105)
Neuroscience (3163)
Neurotech (1)
NextGen: Class of 2026 (6966)
Non-profit (4612)
Now hiring (70)
Obesity (700)
Opinion (342)
Ovarian cancer (170)
Pain (226)
Pancreatic cancer (243)
Parkinson's disease (312)
Partnered (35)
Patents (535)
Patient recruitment (542)
Peanut (63)
People (59678)
Pharmaceutical (86)
Pharmacy benefit managers (33)
Phase 1 (22701)
Phase 2 (31851)
Phase 3 (23906)
Pipeline (5864)
Policy (336)
Postmarket research (2591)
Preclinical (9660)
Press Release (66)
Prostate cancer (265)
Psychedelics (58)
Radiopharmaceuticals (313)
Rare diseases (982)
Real estate (5947)
Recruiting (79)
Regulatory (25882)
Reports (60)
Research institute (2571)
Resumes & cover letters (527)
Rett syndrome (29)
RNA editing (21)
RSV (87)
Schizophrenia (163)
Series A (269)
Series B (205)
Service/supplier (12)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (170)
Sponsored (48)
Startups (3676)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (94)
The Weekly (119)
Vaccines (1099)
Venture capital (98)
Weight loss (481)
Women's health (92)
Worklife (23)
Date
Today (254)
Last 7 days (864)
Last 30 days (2998)
Last 365 days (32008)
2026 (5042)
2025 (32444)
2024 (37220)
2023 (41808)
2022 (53012)
2021 (57525)
2020 (55623)
2019 (48490)
2018 (36865)
2017 (34709)
2016 (34456)
2015 (40108)
2014 (33150)
2013 (28204)
2012 (30007)
2011 (30587)
2010 (28486)
Location
Africa (962)
Alabama (91)
Alaska (7)
Arizona (287)
Arkansas (15)
Asia (44308)
Australia (7516)
California (11926)
Canada (3400)
China (1205)
Colorado (496)
Connecticut (519)
Delaware (351)
Europe (100336)
Florida (1776)
Georgia (384)
Hawaii (3)
Idaho (64)
Illinois (936)
India (74)
Indiana (532)
Iowa (22)
Japan (452)
Kansas (126)
Kentucky (41)
Louisiana (28)
Maine (84)
Maryland (1432)
Massachusetts (8727)
Michigan (347)
Minnesota (658)
Mississippi (6)
Missouri (142)
Montana (34)
Nebraska (29)
Nevada (129)
New Hampshire (87)
New Jersey (3180)
New Mexico (33)
New York (3141)
North Carolina (1609)
North Dakota (10)
Northern California (5814)
Ohio (355)
Oklahoma (21)
Oregon (43)
Pennsylvania (2375)
Puerto Rico (25)
Rhode Island (48)
South America (1299)
South Carolina (66)
Southern California (4640)
Tennessee (175)
Texas (1846)
United States (42500)
Utah (360)
Vermont (1)
Virginia (288)
Washington D.C. (79)
Washington State (977)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
761,788 Results for "the nasdaq stock market california".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026
February 2, 2026
·
1 min read
Press Releases
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq
February 1, 2026
·
4 min read
Press Releases
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
December 8, 2025
·
3 min read
Press Releases
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
November 27, 2025
·
5 min read
Press Releases
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
November 21, 2025
·
7 min read
Press Releases
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
February 4, 2026
·
5 min read
Press Releases
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
February 17, 2026
·
6 min read
Press Releases
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
February 18, 2026
·
6 min read
Press Releases
NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
November 13, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 30, 2025
·
3 min read
1 of 76,179
Next
